News

Vienna joins growing list of bidders to land Europe's drug regulator; Amsterdam the early favorite?

PV experts face new challenges as focus in field moves toward acting on real-world evidence insights.  

Q&A explores the evolution of the patient-centric supply chain and how it's poised to impact the clinical trials landscape.

Supply chain strategies require a close look at the regulatory factors and the drug import hurdles and hopes in the region.

How a single-source temperature management strategy can support a drug’s quality and integrity in transit-a process as important as the destination.

Outlining a decision-making framework that integrates real-world signals with supply planning techniques to reduce risk and avoid potential interruptions.

Learn to partner effectively in the era of collaboration, where the benefits gained will outweigh the challenges if approached correctly

With recent reports indicating that organizations do not have a way of tracking and managing the timeliness of data entry or of site payments, The Metrics Champion Consortium wanted to see if there were opportunities to align incentives in the industry so that both sites and sponsors can achieve their goals with positive impact on clinical trials and patients.

Because of the growing rate of voice assistant applications, such as Alexa, healthcare and life sciences organizations are beginning to design a range of scenarios for deploying these voice assistant platforms in the clinical trial setting.

Since the emergence of the independent IRB sector, sponsors have found that regulatory and ethical review by a single IRB yields important benefits with respect to efficiency, high quality, and consistency in human research protections.

CRO's and sponsors are taking clinical trials to homes. These in-home trials can address participation issues and provide added convenience plus support for patients, but they also come with their own set of risks.

This eBook from Applied Clinical Trials features articles updating actual use studies of ePRO in a large registry trial, as well as challenges, myths, and potential useful strategies associated with “Bring Your Own Device” (BYOD) adoption.